United States Reverse Transcriptase Market Report 2016

Publisher Name :
Date: 05-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Reverse Transcriptase

Revenue, means the sales value of Reverse Transcriptase

This report studies sales (consumption) of Reverse Transcriptase in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Thermo Fisher Scientific, Inc. (U.S.)

- Merck KGaA (Germany)

- New England Biolabs, Inc. (U.S.)

- Promega (U.S.)

- Illumina, Inc. (U.S.)

- Agilent Technologies, Inc. (U.S.)

- F. Hoffmann-la Roche Ltd. (Switzerland)

- Takara Bio Inc. (Japan)

- QIAGEN N.V. (The Netherlands)

- Becton, Dickinson and Company (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Reverse Transcriptase in each application, can be divided into

- PCR

- Sequencing

- Cloning

United States Reverse Transcriptase Market Report 2016

Table of Contents
United States Reverse Transcriptase Market Report 2016
1 Reverse Transcriptase Overview
1.1 Product Overview and Scope of Reverse Transcriptase
1.2 Classification of Reverse Transcriptase
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Reverse Transcriptase
1.3.1 PCR
1.3.2 Sequencing
1.3.3 Cloning
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Reverse Transcriptase (2011-2021)
1.4.1 United States Reverse Transcriptase Sales and Growth Rate (2011-2021)
1.4.2 United States Reverse Transcriptase Revenue and Growth Rate (2011-2021)
2 United States Reverse Transcriptase Competition by Manufacturers
2.1 United States Reverse Transcriptase Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Reverse Transcriptase Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Reverse Transcriptase Average Price by Manufactures (2015 and 2016)
2.4 Reverse Transcriptase Market Competitive Situation and Trends
2.4.1 Reverse Transcriptase Market Concentration Rate
2.4.2 Reverse Transcriptase Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Reverse Transcriptase Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Reverse Transcriptase Sales and Market Share by Type (2011-2016)
3.2 United States Reverse Transcriptase Revenue and Market Share by Type (2011-2016)
3.3 United States Reverse Transcriptase Price by Type (2011-2016)
3.4 United States Reverse Transcriptase Sales Growth Rate by Type (2011-2016)
4 United States Reverse Transcriptase Sales (Volume) by Application (2011-2016)
4.1 United States Reverse Transcriptase Sales and Market Share by Application (2011-2016)
4.2 United States Reverse Transcriptase Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Reverse Transcriptase Manufacturers Profiles/Analysis
5.1 Thermo Fisher Scientific, Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Reverse Transcriptase Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck KGaA (Germany)
5.2.2 Reverse Transcriptase Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck KGaA (Germany) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 New England Biolabs, Inc. (U.S.)
5.3.2 Reverse Transcriptase Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 New England Biolabs, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Promega (U.S.)
5.4.2 Reverse Transcriptase Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Promega (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Illumina, Inc. (U.S.)
5.5.2 Reverse Transcriptase Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Illumina, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Agilent Technologies, Inc. (U.S.)
5.6.2 Reverse Transcriptase Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Agilent Technologies, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-la Roche Ltd. (Switzerland)
5.7.2 Reverse Transcriptase Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Takara Bio Inc. (Japan)
5.8.2 Reverse Transcriptase Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Takara Bio Inc. (Japan) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 QIAGEN N.V. (The Netherlands)
5.9.2 Reverse Transcriptase Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 QIAGEN N.V. (The Netherlands) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Becton, Dickinson and Company (U.S.)
5.10.2 Reverse Transcriptase Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Becton, Dickinson and Company (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Reverse Transcriptase Manufacturing Cost Analysis
6.1 Reverse Transcriptase Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Reverse Transcriptase
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Reverse Transcriptase Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Reverse Transcriptase Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Reverse Transcriptase Market Forecast (2016-2021)
10.1 United States Reverse Transcriptase Sales, Revenue Forecast (2016-2021)
10.2 United States Reverse Transcriptase Sales Forecast by Type (2016-2021)
10.3 United States Reverse Transcriptase Sales Forecast by Application (2016-2021)
10.4 Reverse Transcriptase Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Reverse Transcriptase
Table Classification of Reverse Transcriptase
Figure United States Sales Market Share of Reverse Transcriptase by Type in 2015
Table Application of Reverse Transcriptase
Figure United States Sales Market Share of Reverse Transcriptase by Application in 2015
Figure PCR Examples
Figure Sequencing Examples
Figure Cloning Examples
Figure United States Reverse Transcriptase Sales and Growth Rate (2011-2021)
Figure United States Reverse Transcriptase Revenue and Growth Rate (2011-2021)
Table United States Reverse Transcriptase Sales of Key Manufacturers (2015 and 2016)
Table United States Reverse Transcriptase Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Reverse Transcriptase Sales Share by Manufacturers
Figure 2016 Reverse Transcriptase Sales Share by Manufacturers
Table United States Reverse Transcriptase Revenue by Manufacturers (2015 and 2016)
Table United States Reverse Transcriptase Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Reverse Transcriptase Revenue Share by Manufacturers
Table 2016 United States Reverse Transcriptase Revenue Share by Manufacturers
Table United States Market Reverse Transcriptase Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Reverse Transcriptase Average Price of Key Manufacturers in 2015
Figure Reverse Transcriptase Market Share of Top 3 Manufacturers
Figure Reverse Transcriptase Market Share of Top 5 Manufacturers
Table United States Reverse Transcriptase Sales by Type (2011-2016)
Table United States Reverse Transcriptase Sales Share by Type (2011-2016)
Figure United States Reverse Transcriptase Sales Market Share by Type in 2015
Table United States Reverse Transcriptase Revenue and Market Share by Type (2011-2016)
Table United States Reverse Transcriptase Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Reverse Transcriptase by Type (2011-2016)
Table United States Reverse Transcriptase Price by Type (2011-2016)
Figure United States Reverse Transcriptase Sales Growth Rate by Type (2011-2016)
Table United States Reverse Transcriptase Sales by Application (2011-2016)
Table United States Reverse Transcriptase Sales Market Share by Application (2011-2016)
Figure United States Reverse Transcriptase Sales Market Share by Application in 2015
Table United States Reverse Transcriptase Sales Growth Rate by Application (2011-2016)
Figure United States Reverse Transcriptase Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Reverse Transcriptase Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Promega (U.S.) Basic Information List
Table Promega (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Basic Information List
Table Agilent Technologies, Inc. (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-la Roche Ltd. (Switzerland) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Reverse Transcriptase Sales Market Share (2011-2016)
Table Takara Bio Inc. (Japan) Basic Information List
Table Takara Bio Inc. (Japan) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio Inc. (Japan) Reverse Transcriptase Sales Market Share (2011-2016)
Table QIAGEN N.V. (The Netherlands) Basic Information List
Table QIAGEN N.V. (The Netherlands) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (The Netherlands) Reverse Transcriptase Sales Market Share (2011-2016)
Table Becton, Dickinson and Company (U.S.) Basic Information List
Table Becton, Dickinson and Company (U.S.) Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton, Dickinson and Company (U.S.) Reverse Transcriptase Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Reverse Transcriptase
Figure Manufacturing Process Analysis of Reverse Transcriptase
Figure Reverse Transcriptase Industrial Chain Analysis
Table Raw Materials Sources of Reverse Transcriptase Major Manufacturers in 2015
Table Major Buyers of Reverse Transcriptase
Table Distributors/Traders List
Figure United States Reverse Transcriptase Production and Growth Rate Forecast (2016-2021)
Figure United States Reverse Transcriptase Revenue and Growth Rate Forecast (2016-2021)
Table United States Reverse Transcriptase Production Forecast by Type (2016-2021)
Table United States Reverse Transcriptase Consumption Forecast by Application (2016-2021)
  • 2017-2022 India Astaxanthin Market Report (Status and Outlook)
    Published: 23-Aug-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Astaxanthin market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include - Cyanotech - Fuji - BGG - Yunnan Alphy Biotech - Algatechnologies - Igene Biotechnology - Mera Pharmaceuticals......
  • 2017 Top 5 Astaxanthin Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 23-Aug-2017        Price: US 4960 Onwards        Pages: 169
    "This report will be delivered in 2-3 business days after the order is placed." The Global Astaxanthin market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Astaxanthin in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Astaxanthin Players in each region, with sa......
  • 2017-2022 Japan Astaxanthin Market Report (Status and Outlook)
    Published: 23-Aug-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Astaxanthin market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include - Cyanotech - Fuji - BGG - Yunnan Alphy Biotech - Algatechnologies - Igene Biotechnology - Mera Pharmaceuticals......
  • 2017-2022 Malaysia Astaxanthin Market Report (Status and Outlook)
    Published: 23-Aug-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Astaxanthin market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include - Cyanotech - Fuji - BGG - Yunnan Alphy Biotech - Algatechnologies - Igene Biotechnology - Mera Pharmaceu......
  • 2017-2022 Global Top Countries Astaxanthin Market Report
    Published: 23-Aug-2017        Price: US 4960 Onwards        Pages: 169
    "This report will be delivered in 2-3 business days after the order is placed." The Global Astaxanthin market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Astaxanthin in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle Eas......
  • 2017-2022 Philippines Astaxanthin Market Report (Status and Outlook)
    Published: 23-Aug-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Astaxanthin market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Philippines market, the top players include - Cyanotech - Fuji - BGG - Yunnan Alphy Biotech - Algatechnologies - Igene Biotechnology - Mera Pha......
  • 2017-2022 United States Astaxanthin Market Report (Status and Outlook)
    Published: 23-Aug-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Astaxanthin market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include - Cyanotech - Fuji - BGG - Yunnan Alphy Biotech - Algatechnologies - Igene Biotechnology - Mera......
  • 2017-2022 China Astaxanthin Market Report (Status and Outlook)
    Published: 23-Aug-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Astaxanthin market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - Cyanotech - Fuji - BGG - Yunnan Alphy Biotech - Algatechnologies - Igene Biotechnology - Mera Pharmaceuticals......
  • 2017-2022 Eliquis Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 22-Aug-2017        Price: US 2960 Onwards        Pages: 120
    This report studies the Eliquis market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Eliquis market by product type and applications/end industries. The global Eliquis market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs